The Hitz Report cleared the CIA of injecting crack cocaine into cities across America. Well, suspicions abound that big pharma CEOs are manufacturing Covid variants to sell vaccines. And it might take another congressional report to clear them.
Pharma CEOs Pushing Covid Vaccines
A colleague vented this suspicion about big pharma during a Zoom on Tuesday. Everyone on the call nodded with newfound enlightenment. I smiled. It turned out he was riffing off a report in the Washington Post:
Moderna’s CEO predicted Tuesday that existing coronavirus vaccines would be much less effective at combating Omicron compared with previous variants of the virus, spooking financial markets in the United States, Europe and Asia as scientists rush to learn about the new variant. …
‘[Moderna] and Pfizer cannot get a billion doses next week. The [math] doesn’t work,’ he told the outlet. ‘But could we get the billion doses out by the summer? Sure.’
I smiled because our colleague only echoed my published suspicions. I didn’t say anything. But I only had to cite the titles of a few blog commentaries:
- “Covid-20 Is Coming. What Happens Then,” April 23, 2020,
- “The Great Covid-19 Vaccine Scam Afoot,” July 23, 2020, and
- “Living with Covid – Like the Flu, and ‘Booster’ Means Annual Shot Too,” November 17, 2021.
Covid is big business for big pharma
Except that the “scam afoot” is far worse than I imagined. After all, the one for the flu is, and has always been, a one-shot vaccine.
Johnson & Johnson’s one-shot Covid vaccine has become a two-shot vaccine. We’ll have to take it every year. Ka-ching!
Moderna and Pfizer’s two-shot Covid vaccine has become a three-shot vaccine. We’ll have to take it every year. Ka-ching! Ka-ching!
And now Moderna is hinting that big pharma must peddle a new vaccine to combat Omicron. Ka-ching! Ka-ching! Ka-ching!
At this rate, we’ll get more vaccine shots in our arms each season than the steroid shots professional athletes get in their butts.